AMZNprintsminutestrendsdividendsdrawdownsP/E 28.4macronarrativesvolatilitybuybackssentiment+0.8%marginsMSFTPMI 52.1momentumdividendsflowsPMI 52.1digeststhreadsvolatilityearnings callsvolumesβ 1.24breakoutsnewsflow2s10sliquidityheadlines−1.2%breakoutsnoiseGOOGLbuybacksrevisionstrendsPMI 52.1briefstickersnoiseGDPsentimentchattertranscriptsGOOGLsentimentvolatilitybuybacksMSFTwhispersMETAsessionsyield curves13FfuturesdowngradesPMI 52.1headlinesthe tapeflowsdowngradesfutures+0.8%earnings callstranscriptsclosesgammacatalystsrevisionsvolatilitysentimentchatter+2.41%earnings callssentimentfilingstrends10y 4.21%cyclesbuybackswiresspx 0dtewhisperstickersQ3trendsnewsflowearnings callsWTI 78.2sentimentnoisethreadsrumorsnarrativesFOMCconsensusestimatesmomentumYoY +18%tickersmomentumprintsβ 1.24revisions

momentumheadlines52w hipositioning2s10sfilingstrendsprintstrendsmacrocyclesnoise2s10smacroQ3narrativesheadlinesflowscyclesnarrativesspreadstranscriptsdowngradesupgradeswhisperswhispersminutesthe tapeNDXfuturesminutesyield curves52w hithe tapeFOMCcatalystsbriefsthe tapeNVDAguidancetrends52w hidrawdowns2s10swhispersmomentumdrawdownsbuybacks

PCEliquiditysentimentbreakoutsdowngradesP/E 28.4threadsAAPLSPXvolatilityNDXflowscyclesliquidityestimatesEPS 4.12

MMSI · NASDAQ · Medical - Instruments & Supplies

Merit Medical Systems (MMSI)

Makes single-use devices for vascular access, intervention, endoscopy, oncology, and cardiac therapies.

$87.76

vs last close+0.50 (+0.58%)

In millions of USD, except per-share figures

In millions	Q3 FY23Sep 2023	Q4 FY23Dec 2023	Q1 FY24Mar 2024	Q2 FY24Jun 2024	Q3 FY24Sep 2024	Q4 FY24Dec 2024	Q1 FY25Mar 2025	Q2 FY25Jun 2025	Q3 FY25Sep 2025	Q4 FY25Dec 2025	Q1 FY26Mar 2026	Q2 FY26Jun 2026
Revenue	315	323	324	338	340	355	354	382	384	394	382	419
Cost of revenue	173	188	172	177	182	182	183	198	198	199	197	204
Gross profit	142	135	152	161	158	173	172	184	187	195	185	215
	107	102	116	115	120	136	121	137	144	141	141	155
Research & development	20	22	21	20	21	25	22	24	24	27	23	25
Selling, general & administrative	87	81	94	95	100	108	98	113	120	115	118	129
Other expenses	1	0	0	0	0	3	0	0	0	0	0	0
Operating income	35	33	36	46	37	37	51	47	43	54	44	61
	−5	−1	−2	0	−1	−3	−13	−3	−4	−3	10	−9
Interest income	0	2	7	8	7	5	4	4	4	4	4	4
Interest expense	5	5	8	8	8	8	7	7	7	6	7	12
Other non-operating income	0	−4	−6	−8	−7	−5	6	−3	−3	−3	−16	−3
Income before tax	30	31	34	46	37	33	38	43	39	51	54	51
Income tax expense	4	4	6	10	8	5	8	11	11	13	13	13
Net income from continuing operations	26	28	28	36	28	28	30	33	28	38	41	39
Net income	26	28	28	36	28	28	30	33	28	38	41	39
EPS, basic	$0.45	$0.48	$0.49	$0.61	$0.49	$0.48	$0.51	$0.55	$0.47	$0.64	$0.69	$0.65
EPS, diluted	$0.44	$0.47	$0.48	$0.61	$0.48	$0.46	$0.49	$0.54	$0.46	$0.63	$0.68	$0.65
Weighted average shares, basic	58	58	58	58	58	59	59	59	59	59	60	60
Weighted average shares, diluted	58	58	59	59	60	61	61	61	60	60	60	60
EBITDA	62	63	69	81	74	73	77	84	80	92	93	97
Depreciation & amortization	27	26	27	27	29	32	32	34	34	34	33	34
EBIT	35	37	42	54	44	41	45	50	45	57	60	63